Barely Significant
← all excerpts

Xymedon Activates the Immune Response in Breast Cancer Xenografts.

Biomedicines · 2025 · PMC12730596 · PMID 41463008

Europe PMCDOI
1
hedged sentence
0.1100
closest p · 2.2× alpha
0.1100
boldest claim

The sentences

did not reach statistical significancep ≈ 0.11not close (p > 0.1)
While the tendency toward improved survival did not reach statistical significance ( p ≈ 0.11), the consistent pattern of enhanced immune infiltration and reduced hematologic toxicity suggests clinical relevance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.